Low Anterior Resection vs Lymphadenopathy Syndrome

Side effects and complications in the use of drugs: the feeling of heat (hot flashes), increased sweating, vaginal bleeding or discharge, fatigue, nausea, rash, itching in the genital area, fluid retention, dizziness and depression, weight gain, anorexia, vomiting, constipation, shortness of breath, headache, insomnia, shkirnnyy rash, changes in corneal, cataract, deep vein thrombosis, pulmonary embolism, alopecia, changes in liver enzyme levels, severe liver dysfunction (jaundice) in the presence of metastases in the bones - the development of As much as you like in the early treatment ; increased risk of endometrial hyperplasia, allover cancer (due to estrogen stimulation of the drug). Pharmacotherapeutic group: L02BA03 - agents used in hormone therapy. Dosing and Administration of drugs: adenocarcinoma of the prostate - g / 11.25 mg prolonged every 3 months, breast cancer - g / 1 time every 3 months. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, severe thrombocytopenia, leukopenia, hypercalcemia. 20 mg, 60 mg № 30. Indications for use drugs: first-line drug for allover treatment of hormone dependent metastatic breast cancer in allover and to prevent and allover breast dishormonal hiperplaziy. 10 mg, 20 mg, 30 mg, 40 mg № 10 (10h1), № 30 (10h3), № 100 (10x10) in allover Pharmacotherapeutic group: L02BA02 - anti-estrogenic agents. № 1. The main effect of pharmaco-therapeutic effects of drugs: nonsteroidal tryfeniletylenu derivative, binds to estrogen receptors and provides estrohenopodibnyy, anti-estrogenic (or time) effect, depending on the duration of treatment, sex, body-target; toremifene in the treatment of patients with breast cancer in postmenopausal was revealed a moderate reduction of serum cholesterol and LDL; competitively binds to and inhibits estrohenretseptoramy estrohenoposeredkovanu stimulation of DNA synthesis and replication klitynny; high doses allover antitumor effect, antitumor effect in breast cancer mediated anti-estrogenic effect, but other mechanisms (changes in expression of oncogenes, secretion of growth factors, induction of apoptosis and effects on cell cycle kinetics) also have an antitumor effect. Contraindications to the use of drugs: hypersensitivity to the drug, surgical castration, pregnancy, lactation, vaginal bleeding unknown etiology, etiology of which is not installed, prostate cancer (hormoneindependent). The main effect of pharmaco-therapeutic effects of drugs: estrogen receptor allover that competitively binds with estrogen receptors in degree of kinship that can be compared with that of estradiol. Anti-estrogenic agents. Method of production of drugs: lyophilized powder for making Mr injection of 3.75 mg vial. Indications for use drugs: breast cancer and endometrial cancer, kidney and soft Dual Energy X-ray Absorptionmetry sarcoma, pituitary tumor. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. The main effect of pharmaco-therapeutic effects of drugs: nonsteroidal anti-estrogenic substance with a pronounced effect, due to its ability to prevent the absorption of estrogen receptors in specific areas of target organs, inhibits estrogen receptors in autogenous and slows the progression of tumors that are stimulated by estrogen. Indications for use drugs: adenocarcinoma of the prostate with metastases, breast cancer.